{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:48:18Z","timestamp":1770817698411,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.revmed.2025.04.005","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T06:22:40Z","timestamp":1745562160000},"page":"580-587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prise en charge d\u2019une neutrop\u00e9nie f\u00e9brile post-chimioth\u00e9rapie"],"prefix":"10.1016","volume":"46","author":[{"given":"Xavier","family":"Jannot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-\u00c9douard","family":"Terrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"M\u00e9ndez-Bail\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Bel\u00e9n","family":"Alonso-Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Andr\u00e8s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel","family":"Lorenzo-Villalba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.revmed.2025.04.005_bib0165","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1152\/physrev.00012.2018","article-title":"The neutrophil's role during health and disease","volume":"99","author":"Liew","year":"2019","journal-title":"Physiol Rev"},{"key":"10.1016\/j.revmed.2025.04.005_bib0170","unstructured":"Haute Autorit\u00e9 de sant\u00e9 [Internet]. [cit\u00e9 30\u00a0d\u00e9c 2024]. Neutrop\u00e9nies chroniques. Disponible sur\u00a0: https:\/\/www.has-sante.fr\/jcms\/p_3522408\/fr\/neutropenies-chroniques."},{"issue":"4","key":"10.1016\/j.revmed.2025.04.005_bib0175","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010\u00a0update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.revmed.2025.04.005_bib0180","article-title":"Febrile neutropenia in cancer patient: epidemiology, microbiology, pathophysiology and management","volume":"5","author":"Rasmy","year":"2016","journal-title":"J Cancer Prev Curr Res"},{"key":"10.1016\/j.revmed.2025.04.005_bib0185","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/annonc\/mdw325","article-title":"Management of febrile neutropaenia: ESMO Clinical Practice Guidelines","volume":"27","author":"Klastersky","year":"2016","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.revmed.2025.04.005_bib0190","doi-asserted-by":"crossref","first-page":"e552","DOI":"10.1200\/JOP.2016.019588","article-title":"Cost of cancer-related neutropenia or fever hospitalizations, United States, 2012","volume":"13","author":"Tai","year":"2017","journal-title":"J Oncol Pract"},{"issue":"10","key":"10.1016\/j.revmed.2025.04.005_bib0195","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/cncr.21847","article-title":"Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients","volume":"106","author":"Kuderer","year":"2006","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.revmed.2025.04.005_bib0200","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/jcm8091351","article-title":"State of art of idiosyncratic drug-induced neutropenia or agranulocytosis, with a focus on biotherapies","volume":"8","author":"Andr\u00e8s","year":"2019","journal-title":"J Clin Med"},{"issue":"14","key":"10.1016\/j.revmed.2025.04.005_bib0205","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","article-title":"Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.revmed.2025.04.005_bib0210","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.reaurg.2008.01.010","article-title":"Patient d\u2019oncoh\u00e9matologie neutrop\u00e9nique f\u00e9brile admis en r\u00e9animation, recommandations actuelles et attitude pratique","volume":"17","author":"Mokart","year":"2008","journal-title":"Reanimation"},{"issue":"5","key":"10.1016\/j.revmed.2025.04.005_bib0215","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00277-019-03622-0","article-title":"Management of sepsis in neutropenic cancer patients: 2018\u00a0guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO)","volume":"98","author":"Kochanek","year":"2019","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.revmed.2025.04.005_bib0220","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jaip.2017.08.027","article-title":"Cross-reactivity in \u03b2-lactam allergy","volume":"6","author":"Zagursky","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.revmed.2025.04.005_bib0225","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11882-016-0594-9","article-title":"Cross-reactivity among beta-lactams","volume":"16","author":"Romano","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"issue":"3","key":"10.1016\/j.revmed.2025.04.005_bib0230","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1053\/j.seminhematol.2009.03.002","article-title":"Neutropenic fever syndromes in patients undergoing cytotoxic therapy for acute leukemia and myelodysplastic syndromes","volume":"46","author":"Bow","year":"2009","journal-title":"Semin Hematol"},{"issue":"4","key":"10.1016\/j.revmed.2025.04.005_bib0235","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/cid\/ciac623","article-title":"Empiric vs. preemptive antifungal strategy in high-risk neutropenic patients on fluconazole prophylaxis: a randomized trial of the European Organization for Research and Treatment of Cancer","volume":"76","author":"Maertens","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.revmed.2025.04.005_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/599376","article-title":"Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009\u00a0update by the Infectious Diseases Society of America","volume":"49","author":"Mermel","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.revmed.2025.04.005_bib0245","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.idnow.2021.02.004","article-title":"Antibiotic lock therapy for the conservative treatment of long-term intravenous catheter-related infections in adults and children: when and how to proceed? Guidelines for clinical practice 2020","volume":"51","author":"Albert","year":"2021","journal-title":"Infect Dis Now"},{"issue":"1\u20132","key":"10.1016\/j.revmed.2025.04.005_bib0250","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/10428199609054816","article-title":"Stepdown single agent antibiotic therapy for the management of the high risk neutropenic adult with hematologic malignancies","volume":"23","author":"Horowitz","year":"1996","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.revmed.2025.04.005_bib0255","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/jnci\/djk028","article-title":"Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy","volume":"99","author":"Hershman","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.revmed.2025.04.005_bib0260","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1046\/j.1537-2995.2000.40040414.x","article-title":"Functional characteristics of neutrophils collected and stored after administration of G-CSF","volume":"40","author":"Leavey","year":"2000","journal-title":"Transfusion (Paris)"},{"issue":"18","key":"10.1016\/j.revmed.2025.04.005_bib0265","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1182\/blood-2015-05-645986","article-title":"Efficacy of transfusion with granulocytes from G-CSF\/dexamethasone\u00a0\u2013\u00a0treated donors in neutropenic patients with infection","volume":"126","author":"Price","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.revmed.2025.04.005_bib0270","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2141.2004.05221.x","article-title":"The role of granulocyte transfusions in neutropenic patients","volume":"127","author":"Bishton","year":"2004","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.revmed.2025.04.005_bib0275","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1182\/blood.V81.7.1675.1675","article-title":"Therapeutic granulocyte transfusions in 1993","volume":"81","author":"Strauss","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2025.04.005_bib0280","unstructured":"Granulocyte transfusions\u00a0\u2013\u00a0UpToDate [Internet]. [cit\u00e9 30\u00a0d\u00e9c 2024]. Disponible sur\u00a0: https:\/\/www.uptodate.com\/contents\/granulocyte-transfusions?search=gtx&source=search_result&selectedTitle=1%7E2&usage_type=default&display_rank=1."},{"issue":"10","key":"10.1016\/j.revmed.2025.04.005_bib0285","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa044097","article-title":"Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia","volume":"353","author":"Bucaneve","year":"2005","journal-title":"N Engl J Med"},{"issue":"12_Part_1","key":"10.1016\/j.revmed.2025.04.005_bib0290","doi-asserted-by":"crossref","first-page":"979","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00008","article-title":"Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients","volume":"142","author":"Gafter-Gvili","year":"2005","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.revmed.2025.04.005_bib0295","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1182\/blood-2005-09-3624","article-title":"Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation\u00a0\u2013\u00a0a randomized double-blind placebo-controlled study","volume":"107","author":"Boeckh","year":"2006","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.revmed.2025.04.005_bib0300","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.revmed.2025.04.005_bib0305","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3390\/v15020439","article-title":"Herpes simplex virus and varicella zoster virus infections in cancer patients","volume":"15","author":"Tayyar","year":"2023","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.revmed.2025.04.005_bib0310","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.revmed.2025.04.005_bib0315","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejca.2010.10.013","article-title":"2010\u00a0update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours","volume":"47","author":"Aapro","year":"2011","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.revmed.2025.04.005_bib0320","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMct1210890","article-title":"Colony-stimulating factors for febrile neutropenia during cancer therapy","volume":"368","author":"Bennett","year":"2013","journal-title":"N Engl J Med"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866325005363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866325005363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T15:16:09Z","timestamp":1759504569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866325005363"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0248866325005363"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2025.04.005","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prise en charge d\u2019une neutrop\u00e9nie f\u00e9brile post-chimioth\u00e9rapie","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2025.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI).","name":"copyright","label":"Copyright"}]}}